Testing new drugs to improve diuretic effectiveness in heart and kidney patients
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance
This study is looking at a new way to help people with heart failure, kidney disease, or liver disease who struggle to get rid of extra fluid, by testing a special treatment that could make their diuretic medications work better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10904756 on NIH RePORTER |
What this research studies
This research focuses on addressing diuretic resistance, a common issue in patients with congestive heart failure, chronic kidney disease, and liver disease. It investigates the use of novel Kir4.1/5.1 inhibitors to enhance the effectiveness of diuretics, which are medications used to remove excess fluid from the body. By targeting specific channels in the kidneys, the research aims to improve fluid management in patients who do not respond well to standard diuretics. The approach involves preclinical validation, meaning it will be tested in laboratory settings before any potential clinical application.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with congestive heart failure, chronic kidney disease, or chronic liver disease who experience diuretic resistance.
Not a fit: Patients who do not have fluid overload issues or those with conditions unrelated to diuretic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from fluid overload due to heart and kidney conditions.
How similar studies have performed: While the approach of using Kir4.1/5.1 inhibitors is relatively novel, there is growing interest in developing new diuretics to overcome resistance, indicating potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Denton, Jerod S. — Vanderbilt University Medical Center
- Study coordinator: Denton, Jerod S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.